Becker's ASC

Alpha-2 Agonists Reduce Opioid Use for Post-Surgical Patients, Study Says

Researchers at Geneva University Hospital in Geneva, Switzerland, found that the use of alpha-2 agonists with opioids in surgical patients decreased post-surgical opioid use by 25 to 30 percent. The ...
Business Wire

Synthekine Advances IL-2 Partial Agonist, STK-012, into Clinical Investigation for Treatment of Solid Tumors

MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced it is advancing its IL-2 partial agonist, STK-012, into clinical investigation ...
Hosted on MSN

5 outdated blood pressure drugs that are no longer recommended

Alpha-blockers and Alpha-2 agonists are not recommended as first-choice treatment for high blood pressure. Beta-blockers can worsen asthma symptoms and other lung conditions. Vasodilators and loop ...
MarketWatch

Dragonfly Therapeutics to Present Preclinical Data on Clinical-Stage DF6215, its Engineered IL-2R alpha-active Agonist, and DF9001, its EGFR-targeting TriNKET(R), at the ...

DF9001 is currently being evaluated for the treatment of Non-Small Cell Lung Cancer, Renal Cell Carcinoma and Head and Neck Squamous Cell Carcinoma DF6215 is currently being evaluated for the ...